|
1
|
Lusis AJ: Atherosclerosis. Nature.
407:233–241. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ross R: Atherosclerosis - an inflammatory
disease. N Engl J Med. 340:115–126. 1999. View Article : Google Scholar
|
|
3
|
Bevilacqua MP, Nelson RM, Mannori G and
Cecconi O: Endothelial-leukocyte adhesion molecules in human
disease. Annu Rev Med. 45:361–378. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bobryshev YV, Lord RS, Rainer SP and Munro
VF: VCAM-1 expression and network of VCAM-1 positive vascular
dendritic cells in advanced atherosclerotic lesions of carotid
arteries and aortas. Acta Histochem. 98:185–194. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
O'Brien KD, McDonald TO, Chait A, Allen MD
and Alpers CE: Neovascular expression of E-selectin, intercellular
adhesion molecule-1 and vascular cell adhesion molecule-1 in human
atherosclerosis and their relation to intimal leukocyte content.
Circulation. 93:672–682. 1996. View Article : Google Scholar
|
|
6
|
O'Brien KD, Allen MD, McDonald TO, Chait
A, Harlan JM, Fishbein D, McCarty J, Ferguson M, Hudkins K and
Benjamin CD: Vascular cell adhesion molecule-1 is expressed in
human coronary atherosclerotic plaques. Implications for the mode
of progression of advanced coronary atherosclerosis. J Clin Invest.
92:945–951. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Owens GK, Kumar MS and Wamhoff BR:
Molecular regulation of vascular smooth muscle cell differentiation
in development and disease. Physiol Rev. 84:767–801. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Falk E: Pathogenesis of atherosclerosis. J
Am Coll Cardiol. 47(Suppl 8): C7–C12. 2006. View Article : Google Scholar
|
|
9
|
Braun M, Pietsch P, Schrör K, Baumann G
and Felix SB: Cellular adhesion molecules on vascular smooth muscle
cells. Cardiovasc Res. 41:395–401. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jang Y, Lincoff AM, Plow EF and Topol EJ:
Cell adhesion molecules in coronary artery disease. J Am Coll
Cardiol. 24:1591–1601. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Davies MJ, Gordon JL, Gearing AJ, Pigott
R, Woolf N, Katz D and Kyriakopoulos A: The expression of the
adhesion molecules ICAM-1, VCAM-1, PECAM and E-selectin in human
atherosclerosis. J Pathol. 171:223–229. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Libby P and Li H: Vascular cell adhesion
molecule-1 and smooth muscle cell activation during atherogenesis.
J Clin Invest. 92:538–539. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu Printseva O, Peclo MM and Gown AM:
Various cell types in human atherosclerotic lesions express ICAM-1.
Further immunocytochemical and immunochemical studies employing
monoclonal antibody 10F3. Am J Pathol. 140:889–896. 1992.
|
|
14
|
Huo Y and Ley K: Adhesion molecules and
atherogenesis. Acta Physiol Scand. 173:35–43. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kitaoka F, Kakiuchi N, Long C, Itoga M,
Mitsue A, Mouri C and Mikage M: Molecular characterization of
akebia plants and the derived traditional herbal medicine. Biol
Pharm Bull. 32:665–670. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mimaki Y, Doi S, Kuroda M and Yokosuka A:
Triterpene glycosides from the stems of Akebia quinata. Chem
Pharm Bull. 55:1319–1324. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Choi J, Jung HJ, Lee KT and Park HJ:
Antinociceptive and anti-inflammatory effects of the saponin and
sapogenins obtained from the stem of Akebia quinata. J Med
Food. 8:78–85. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tsuchiya S, Yamabe M, Yamaguchi Y,
Kobayashi Y, Konno T and Tada K: Establishment and characterization
of a human acute monocytic leukemia cell line (THP-1). Int J
Cancer. 26:171–176. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen C, Chou C, Sun Y and Huang W: Tumor
necrosis factor alpha-induced activation of downstream NF-kappaB
site of the promoter mediates epithelial ICAM-1 expression and
monocyte adhesion. Involvement of PKCalpha, tyrosine kinase and
IKK2, but not MAPKs, pathway. Cell Signal. 13:543–553. 2001.
View Article : Google Scholar
|
|
20
|
Collins T, Read MA, Neish AS, Whitley MZ,
Thanos D and Maniatis T: Transcriptional regulation of endothelial
cell adhesion molecules: NF-kappa B and cytokine-inducible
enhancers. FASEB J. 9:899–909. 1995.PubMed/NCBI
|
|
21
|
Ju JW, Kim SJ, Jun CD and Chun JS: p38
kinase and c-Jun N-terminal kinase oppositely regulates tumor
necrosis factor alpha-induced vascular cell adhesion molecule-1
expression and cell adhesion in chondrosarcoma cells. IUBMB Life.
54:293–299. 2002. View Article : Google Scholar
|
|
22
|
Ho AW, Wong CK and Lam CW: Tumor necrosis
factor-alpha up-regulates the expression of CCL2 and adhesion
molecules of human proximal tubular epithelial cells through MAPK
signaling pathways. Immunobiology. 213:533–544. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brasier AR: The nuclear
factor-kappaB-interleukin-6 signalling pathway mediating vascular
inflammation. Cardiovasc Res. 86:211–218. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pahl HL: Activators and target genes of
Rel/NF-kappaB transcription factors. Oncogene. 18:6853–6866. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Waddick KG and Uckun FM: Innovative
treatment programs against cancer: II. Nuclear factor-kappaB
(NF-kappaB) as a molecular target. Biochem Pharmacol. 57:9–17.
1999. View Article : Google Scholar : PubMed/NCBI
|
